BACKGROUND: No published studies investigating drug-related problems (DRPs) in children visiting emergency department (ED) in either the Kingdom of Saudi Arabia (KSA) or the United Kingdom (UK) were identified. OBJECTIVE: To determine the frequency and characteristics of DRPs in paediatric patients attending ED in the KSA and the UK. METHOD: An observational study. DRPs were identified by a researcher, reviewing the medical records of children attending the ED during a three-month period in KSA and a 1 month period in UK; severity and preventability of the DRPs were assessed. Incidence of DRPs overall and in each country was calculated. RESULTS: A total of 253 patients (KSA n = 143, UK n = 110) were included. Fifty-five patients (22%; 55/253), experienced 69 DRPs. 2% (5/253) of the patients attended the ED due to DRPs. Overall incidence was 21.7% (95% CI, 16.8-27.3). 78% (54/69) of the DRPs were assessed as preventable; 33% (23/69) as of moderate severity. CONCLUSION: DRPs were common in paediatric patients attending EDs; the majority were preventable. Further study is needed to investigate the impact of mild and moderate DRPs on paediatric patients' health and also to improve the care provided to minimise the occurrence of preventable DRPs.
BACKGROUND: No published studies investigating drug-related problems (DRPs) in children visiting emergency department (ED) in either the Kingdom of Saudi Arabia (KSA) or the United Kingdom (UK) were identified. OBJECTIVE: To determine the frequency and characteristics of DRPs in paediatric patients attending ED in the KSA and the UK. METHOD: An observational study. DRPs were identified by a researcher, reviewing the medical records of children attending the ED during a three-month period in KSA and a 1 month period in UK; severity and preventability of the DRPs were assessed. Incidence of DRPs overall and in each country was calculated. RESULTS: A total of 253 patients (KSA n = 143, UK n = 110) were included. Fifty-five patients (22%; 55/253), experienced 69 DRPs. 2% (5/253) of the patients attended the ED due to DRPs. Overall incidence was 21.7% (95% CI, 16.8-27.3). 78% (54/69) of the DRPs were assessed as preventable; 33% (23/69) as of moderate severity. CONCLUSION: DRPs were common in paediatric patients attending EDs; the majority were preventable. Further study is needed to investigate the impact of mild and moderate DRPs on paediatric patients' health and also to improve the care provided to minimise the occurrence of preventable DRPs.
Authors: Asia N Rashed; Ian C K Wong; Noel Cranswick; Stephen Tomlin; Wolfgang Rascher; Antje Neubert Journal: Eur J Clin Pharmacol Date: 2011-12-14 Impact factor: 2.953
Authors: Asia N Rashed; Antje Neubert; Stephen Tomlin; John Jackman; Hani Alhamdan; Adnan AlShaikh; Ahmed Attar; Mohammed Aseeri; Lynda Wilton; Ian C K Wong Journal: Eur J Clin Pharmacol Date: 2012-05-30 Impact factor: 2.953
Authors: Asia N Rashed; Lynda Wilton; Charles C H Lo; Benjamin Y S Kwong; Suzanne Leung; Ian C K Wong Journal: Br J Clin Pharmacol Date: 2014-05 Impact factor: 4.335
Authors: Norkasihan Ibrahim; Ian Chi Kei Wong; Stephen Tomlin; Manish D Sinha; Lesley Rees; Yogini Jani Journal: Pediatr Nephrol Date: 2014-10-29 Impact factor: 3.714
Authors: Abubakar Ibrahim Jatau; Myat Moe Thwe Aung; Tuan Hairulnizam Tuan Kamauzaman; Ab Fatah Ab Rahman Journal: Drugs Real World Outcomes Date: 2015-10-23
Authors: Ivan Lo Giudice; Eleonora Mocciaro; Claudia Giardina; Maria Antonietta Barbieri; Giuseppe Cicala; Maria Gioffrè-Florio; Giuseppe Carpinteri; Aulo Di Grande; Edoardo Spina; Vincenzo Arcoraci; Paola Maria Cutroneo Journal: BMC Pharmacol Toxicol Date: 2019-04-27 Impact factor: 2.483
Authors: Aeshah AlAzmi; Omaima Ahmed; Hani Alhamdan; Hanan AlGarni; Rawan Mohammed Elzain; Rihad S AlThubaiti; Mohammed Aseeri; Adnan Al Shaikh Journal: Drug Healthc Patient Saf Date: 2019-11-28